Spectrum is green for US Fusilev patent extension
This article was originally published in Scrip
Executive Summary
Spectrum Pharmaceuticals got a two-year-plus extension from the US Patent and Trademark Office (USPTO) for its folate analog Fusilev (levoleucovorin) for injection.